Follow
Aysegul Erman
Title
Cited by
Cited by
Year
Rab18 and Rab43 have key roles in ER-Golgi trafficking
SY Dejgaard, A Murshid, A Erman, O Kızılay, D Verbich, R Lodge, ...
Journal of cell science 121 (16), 2768-2781, 2008
1692008
Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women
A Erman, A Veilleux, A Tchernof, CG Goodyer
International journal of obesity 35 (12), 1511-1519, 2011
412011
Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: a systematic review and meta‐analysis
A Erman, A Sathya, A Nam, JM Bielecki, JJ Feld, HH Thein, WWL Wong, ...
Journal of viral hepatitis 25 (5), 502-513, 2018
382018
Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors
A Erman, M Wabitsch, CG Goodyer
International journal of obesity 35 (12), 1520-1529, 2011
292011
Antiviral treatment for treatment-na´ve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials
WWL Wong, P Pechivanoglou, J Wong, JM Bielecki, A Haines, A Erman, ...
Systematic reviews 8 (1), 1-15, 2019
272019
Exploring the effect of collective cultural attributes on Covid-19-related public health outcomes
A Erman, M Medeiros
Frontiers in psychology, 884, 2021
24*2021
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
A Erman, MD Krahn, T Hansen, J Wong, JM Bielecki, JJ Feld, WWL Wong, ...
BMJ open 9 (11), e027491, 2019
23*2019
Model-based projection of health and economic effects of screening for hepatitis C in Canada
WWL Wong, A Erman, JJ Feld, M Krahn
Canadian Medical Association Open Access Journal 5 (3), E662-E672, 2017
232017
Cost analysis of Greenlight photoselective vaporization of the prostate compared to transurethral resection of the prostate for benign prostatic hyperplasia
L Masucci, A Erman, MD Krahn, D Elterman
Canadian Urological Association Journal 12 (12), 382, 2018
142018
Pharmacotherapy vs surgery as initial therapy for patients with moderate‐to‐severe benign prostate hyperplasia: a cost‐effectiveness analysis
A Erman, L Masucci, MD Krahn, DS Elterman
BJU international 122 (5), 879-888, 2018
132018
Cost-effectiveness analysis of extended adjuvant endocrine therapy in the treatment of post-menopausal women with hormone receptor positive breast cancer
A Erman, A Nugent, E Amir, PC Coyte
Breast cancer research and treatment 145 (2), 267-279, 2014
112014
A vaccination strategy for Ontario COVID-19 hotspots and essential workers
S Mishra, NM Stall, H Ma, A Odutayo, JC Kwong, U Allen, KA Brown, ...
Science Briefs of the Ontario COVID-19 Science Advisory Table 2 (26), 2021
82021
The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach
A Erman, WWL Wong, JJ Feld, P Grootendorst, MD Krahn
Liver International 50 (1), 51-59, 2020
42020
Personality traits of world leaders and differential policy responses to the COVID-19 pandemic
M Medeiros, A Nai, A Erman, E Young
Social Science & Medicine, 115358, 2022
1*2022
Variant-of-concern-attributable health and health system-related outcomes: a population-level propensity-score matched cohort study
A Erman, S Mishra, KA Barrett, S Mac, D Naimark, B Sander
medRxiv, 2021
12021
FINAL CENSORED REPORT: Treatment for chronic hepatitis B
WW Wong, P Pechlivanoglou, A Erman, Y Saeed, M Younis, NZ Rayad, ...
12015
A Systematic Review of the Cost-Effectiveness of Cleft Care in Low-and Middle-Income Countries: What is Needed?
KY Chung, G Ho, A Erman, JM Bielecki, CR Forrest, B Sander
The Cleft Palate-Craniofacial Journal, 10556656221111028, 2022
2022
Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study
Y Sahakyan, A Erman, N Bhojani, B Chughtai, KC Zorn, B Sander, ...
Prostate Cancer and Prostatic Diseases, 1-6, 2022
2022
MP01-12 PHARMACOTHERAPY VS MINIMALLY INVASIVE THERAPIES AS INITIAL THERAPY FOR PATIENTS WITH BENIGN PROSTATE HYPERPLASIA: A MICROSIMULATION MODEL
Y Sahakyan, A Erman, N Bhojani, B Chughtai, KC Zorn, B Sander, ...
The Journal of Urology 207 (Supplement 5), e5, 2022
2022
Pharmacotherapy vs. minimally invasive therapies as initial therapy for patients with benign prostate hyperplasia: A microsimulation model
Y Sahakyan, A Erman, N Bhojani, B Chughtai, KC Zorn, B Sander, ...
EUROPEAN UROLOGY 81, S1075-S1076, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20